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Background. There is an increasing demand for noninvasive brain tumor biomarkers to guide surgery and subsequent oncother-
apy. We present a novel whole-brain diffusion tensor imaging (DTI) segmentation (D-SEG) to delineate tumor volumes of interest
(VOIs) for subsequent classification of tumor type. D-SEG uses isotropic (p) and anisotropic (q) components of the diffusion tensor
to segment regions with similar diffusion characteristics.
Methods. DTI scans were acquired from 95 patients with low- and high-grade glioma, metastases, and meningioma and from 29
healthy subjects. D-SEG uses k-means clustering of the 2D (p,q) space to generate segments with different isotropic and aniso-
tropic diffusion characteristics.
Results. Our results are visualized using a novel RGB color scheme incorporating p, q and T2-weighted information within each seg-
ment. The volumetric contribution of each segment to gray matter, white matter, and cerebrospinal fluid spaces was used to generate
healthy tissue D-SEG spectra. Tumor VOIs were extracted using a semiautomated flood-filling technique and D-SEG spectra were
computed within the VOI. Classification of tumor type using D-SEG spectra was performed using support vector machines. D-SEG
was computationally fast and stable and delineated regions of healthy tissue from tumor and edema. D-SEG spectra were consistent
for each tumor type, with constituent diffusion characteristics potentially reflecting regional differences in tissue microstructure. Sup-
port vector machines classified tumor type with an overall accuracy of 94.7%, providing better classification than previously reported.
Conclusions. D-SEG presents a user-friendly, semiautomated biomarker that may provide a valuable adjunct in noninvasive brain
tumor diagnosis and treatment planning.
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The imaging characteristics of newly identified brain tumors
may indicate the likely diagnosis and treatment strategy.
Until recently, certain cases of malignant glioma (glioblastoma)
and metastatic brain tumors were often considered untreat-
able.1,2 Advances in chemotherapeutic and radiotherapy regi-
mens3 and appreciation of the role of surgical resection in
survival4 resulted in more patients being recommended for
treatment. Histological confirmation is usually necessary prior
to commencing therapy, yet there remain risks associated
with surgery.5 Noninvasive, accurate, and reproducible bio-
markers are required to assist with decision making.
Typical “preoperative” tumor MR protocols include
T2-weighted, diffusion-weighted, and gadolinium enhanced
T1-weighted imaging to evaluate lesion cellularity, vascularity,
and blood–brain barrier integrity. These “conventional”
sequences yield a correct diagnosis in the majority of cases.
However, there remains a lack of specificity in challenging sce-
narios, such as differentiating: (i) malignant (World Health Orga-
nization [WHO] grades III and IV) glial tumors from low-grade
glioma (WHO grades I and II),6 (ii) malignant glioma from soli-
tary necrotic or cystic cerebral metastasis,7 and (iii) benign
en-plaque meningeal tumors (eg, meningioma) from durally
based metastatic deposits.8
Quantifying microscopic diffusion of water molecules
using MRI is a proposed surrogate marker of tissue micro-
structure.9 Brain tumors alter regional brain architecture
due to differences in cell structure, size, and density and
the presence of necrosis and edema. Consequently, tumor
MR diffusion properties may identify diagnostic intertumoral
differences. Whole-brain maps of diffusion metrics can be
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generated from diffusion tensor imaging (DTI) data.10,11
Mean diffusivity (MD) provides a magnitude of isotropic dif-
fusion (in mm2 s21), and fractional anisotropy (FA) provides
a scalar value of diffusion directionality. Differences in MD
and FA among tumor types and grades of malignancy
have been investigated with mixed success.12 – 16
An alternative decomposition of the diffusion tensor is into
isotropic (p) and anisotropic (q) components,17 where p is a
scaled measure of MD, and q is a measure of deviation of the
principal diffusivities from isotropy, both in units of mm2 s21:
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where l1, l2, and l3 are the principal diffusivities of the diffu-
sion tensor and MD¼ (l1 + l2 + l3)/3. Each image voxel
from a DTI dataset can be represented as a coordinate in a
2D Cartesian plane referred to as (p,q) space.
The majority of studies investigating DTI metrics in tumor
diagnosis utilize manually determined regions of interest
(ROIs) subjectively placed within tumor regions (eg, solid/ne-
crotic tumor component, normal-appearing brain, perilesional
tissue). ROI placement guided by intensity boundaries on con-
ventional MR images is generally performed on a single image
slice, yielding an ROI smaller than the entire lesion.
Automated lesion segmentation is an alternative ROI selec-
tion technique18 but has been applied mostly to conventional
MRI,19 – 22 with few examples of tumor segmentation from
diffusion-weighted imaging (DWI) or DTI datasets.23,24 Ideally,
tumor segmentation requires minimal user input, is computa-
tionally efficient, and classifies images into regions with different
pathological microstructures. In whole-brain DTI datasets, this
corresponds to segmenting regions sharing similar diffusion
characteristics to reflect similar tissue microstructure.
We present a novel diffusion segmentation (D-SEG) algo-
rithm applied to (p,q) space. D-SEG automatically segments
and visualizes regions of similar diffusion characteristics. Pat-
tern recognition by k-means clustering25 is used to iteratively
segment (p,q) space into K nonoverlapping clusters. The num-
ber, K, of initial centroids is specified a priori according to the
number of desired clusters26 as determined by functional and
anatomical considerations. Tumor tissue boundaries identified
on D-SEG maps are used to semiautomatically delineate vol-
umes of interest (VOIs). The relative proportion of each (p,q)
segment within the VOI reflects the composition of isotropic
and anisotropic diffusion within the lesion, providing a “signa-
ture” referred to as a D-SEG spectrum. D-SEG is applied to a
cohort of young healthy subjects and a large cohort of
tumor patients to investigate lesion-specific diffusion signa-
tures as surrogate markers of tumor microstructure. Classifi-
cation of D-SEG spectra into tumor types is then performed
using support vector machines (SVMs).
Materials and Methods
Patients
All patients participating in this study signed a consent form ap-
proved by the research ethics committee. Ninety-five patients
(mean age 56.3+16.1 y) and 29 healthy subjects (mean age
27.4+7.3 y) were prospectively recruited over an 18-month pe-
riod. Patient inclusion criteria were: a radiologically diagnosed
lesion occupying intracranial space due to undergo surgery
with subsequent histopathological confirmation of tumor
type; age over 16 years; and ability to lie flat for 1 h. Tumor
types were: 11 WHO grade I meningiomas, 26 metastases, 31
solid grade IV glioblastomas, 7 cystic grade IV glioblastomas, 1
grade III anaplastic astrocytoma, and 19 grade II low-grade gli-
omas. Of the 95 patients, 82 underwent lesion debulking/resec-
tion (11 meningiomas, 26 metastases, 28 high grade gliomas,
16 low-grade gliomas) and 13 had a stereotactic biopsy (10
grade IV glioblastomas, 3 low-grade gliomas). All cases of glio-
blastoma displayed contrast enhancement on T1-weighted im-
aging, and of the 19 cases of low-grade glioma, 16 did not
enhance and 3 displayed a faint blush of enhancement. Target-
ed biopsy of the enhancing region in the low-grade glioma pa-
tients did not reveal focal cellular anaplasia. Of the 26
metastases studied, 10 originated from lung carcinoma, 7
from breast carcinoma, 3 melanoma, 3 renal, 2 bowel adenocar-
cinoma, and 1 prostate. Tumors were all intra-axial and supra-
tentorial; 14 were solitary and 12 were multiple lesions.
Image Acquisition
DTIs were acquired using 2 similar 1.5T scanners (termed A and
B). Although scanner acquisitions differed, echo times (TEs)
were similar, and repetition times (TRs) were long enough to
avoid T1-relaxation effects. Voxel sizes and DTI signal to noise
were similar on each scanner due to acquisition of 12 and 61
diffusion gradient directions, with 4 and 1 average(s), respec-
tively. Whole-brain coverage was achievable in a single acquisi-
tion using scanner B, reducing total acquisition time.
Scanner A
MRIs were acquired for 41 patients (6 meningiomas, 11 metas-
tases, 13 glioblastomas, 11 grade II gliomas) and 16 young
healthy subjects (1.5T General Electric Signa LX, quadrature
head coil, maximum gradient strength 22 mT m21). Axial DTIs
were acquired using a single-shot spin echo planar imaging
(EPI) sequence. Following acquisition at b¼ 0 s mm22 (repeated
10 times), DWIs were acquired (b¼ 1000 s mm22) with diffusion
gradients applied in 12 directions (TE, 88 ms; TR, 8000 ms; field
of view¼ 240×240 mm2; matrix size¼ 96×96; slice gap,
2.8 mm; slice thickness, 2.8 mm), providing near isotropic voxels
2.5×2.5×2.8 mm3. Two interleaved acquisitions were acquired,
providing contiguous whole-brain coverage over 50 slices and re-
peated 4 times to improve signal to noise. The T2-weighted EPI
b¼ 0 s mm22 images are subsequently referred to as b¼ 0
maps.
Scanner B
MRIs were acquired for 54 patients (5 meningiomas, 15 metas-
tases, 25 glioblastomas, 1 anaplastic astrocytoma, and 8 grade
II gliomas) and 13 young healthy subjects (1.5T GE Signa HDx,
8-channel head coil, maximum gradient strength 33 mT m21).
Differences in DTI acquisition on scanner B compared with
scanner A were that whole-brain DWIs were acquired at a
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higher angular resolution in 61 noncollinear diffusion gradient
directions (TE, 94 ms; TR, 14 000 ms; slice thickness, 2.5 mm;
no slice gap), providing 2.5 mm isotropic voxels over 55 slices.
Image Preprocessing
DWIs were realigned to remove eddy current distortions using
eddy correct (FMRIB Software Library, http://www.fmrib.ox.ac.
uk/fsl) prior to generating p and q maps. Images were skull
stripped using Brain Extraction Tool (FMRIB Software).
Reproducibility of DTI Data Between Scanners
Between-scanner reproducibility was estimated with 5 healthy
subjects. For each subject, b¼ 0 maps acquired on scanner B
were coregistered to those obtained on scanner A using an
affine transformation (Statistical Parametric Mapping [SPM]8,
http://www.fil.ion.ucl.ac.uk/SPM8) and were used to coregister
p and q maps. Tissue probability maps of gray matter (GM),
white matter (WM), and CSF were computed from each b¼ 0
map SPM8.27 Hard segmentation maps were computed for
GM, WM, and CSF (eg, for GM, p(GM) .p(WM)+ p(CSF) at each
voxel). Voxel-wise comparison of p and q values yielded intra-
class correlation coefficients for GM and WM.
DTI Segmentation Algorithm
Histograms of p and q were computed across all brain voxels in
all subjects (n¼ 123). High intensity noise was removed from
the p and q distributions by computing 99.99 percentiles and
assigning values above this threshold to 1.0. Remaining voxels
were scaled between 0 and 1, generating dataset-wide non-
Gaussian p and q histograms (Fig. 1A and B).
The p and q maps are a set of observations (x1, x2, . . . , xn)
where each observation is a 2D real vector in (p,q) space
(Fig. 1C). Clustering by k-means partitions the n data points
into K disjoint subsets Sj, where j = {1, 2, . . . , 16} by minimizing
the within-cluster sum of squares objective function,
J =
∑K
j=1
∑
n[Sj
||xn − mj||2,
where xn is a vector representing the nth data point, and mj is
the geometric centroid of the data points in Sj. Centroids of
the initial clusters (m1,m2, . . . ,mn) were selected by separating
(p,q) space into K segments of roughly equal size according to
median and quartile values of p and q (Fig. 1D, Table 1). These
initial conditions preserve the non-Gaussian structure of the p
and q histograms in the cluster initialization. As the data are
non-Gaussian, the centroid was defined to be the median
(p,q) coordinate of each cluster. The following 2 steps of the al-
gorithm25 were repeated:
Step 1. Assignment step: Assign each voxel to the cluster
whose centroid is closest in (p,q) space, thus partitioning the
voxels into K clusters, shown here at the tth iteration,
S(t)i = {xj : ||xj − m(t)i || ≤ ||xj − m(t)i∗ || for all i∗, i [ {1, . . . , K}}.
Step 2. Update step: Calculate the new centroids for each
cluster, shown for iteration t+ 1,
m(t+1)i =
1
|S(t)i |
∑
xj[S
(t)
i
xj.
An iterative exponential decrease in the number of voxels
changing cluster was observed. D-SEG was terminated after
250 iterations, after which convergence was achieved. Final
segmentation of (p,q) space is displayed as a Voronoi tessella-
tion28 (Fig. 1E).
Selection of K
We tested our segmentation technique using a range of differ-
ent K values (K¼ 4, 9, 16, and 25). K¼ 16 was selected because
it provided the optimum computation time and allowed identi-
fication of our a priori postulated regions within a tumor-
affected brain, namely: (i) healthy brain GM, (ii) heterogeneous
WM, (iii) CSF, (iv) solid tumor, (v) regional necrosis, (vi) tumor-
associated cystic regions, (vii) perilesional edema, (viii) perile-
sional tumor infiltration, and (ix) distant edema while also iden-
tifying differences among the 5 tumor types studied.
D-SEG Color Visualization Technique
A novel RGB coloring scheme was developed to illustrate the
relative magnitude of p and q diffusion and T2-weighting
(from the b¼ 0 map) within each D-SEG cluster. A histogram
of T2-weighted intensities was computed for each subject,
the 99.99 percentile was discarded, and resultant values were
scaled between 0 and 1. Median p, q, and T2-weighted values
for cluster centroids were ranked from 1 (lowest median) to 16
(highest median). Rank scores were used to generate an RGB
color by assigning T2-weighting, p, and q to the red, green,
and blue channels, respectively (Fig. 2). Color maps were visu-
alized using MRIcro.29
D-SEG in Healthy Subjects
Hard segmentation of b¼ 0 maps into GM, WM, and CSF was
computed using SPM8 as described above to mask each of
the D-SEG maps. The proportion of each segment within each
tissue type was determined and plotted to provide average
D-SEG spectra across all healthy subjects.
Tumor and Edema Volume of Interest Delineation
A combined tumor and edema VOI was semiautomatically de-
lineated for each patient using a 4-voxel neighborhood recur-
sive flood-filling algorithm on a slice-by-slice basis. Seed
voxel(s) were placed within tumor and edema by a neurosur-
geon (T.J.) with 6 years of training and 4 years of clinical and
research experience of lesion delineation. T.J. was blinded to
the histopathological diagnosis, and the semiautomated seg-
mentation was performed directly from the D-SEG maps with
conventional T2-weighted and T1-weighted images (+/2 con-
trast) as additional visual guides. No manual editing of the VOI
was performed post hoc.
Jones et al.: Tumor classification by a novel DTI segmentation
468
Fig. 1. D-SEG clustering technique. Normalized histograms of (A) p and (B) q across all subjects (n¼ 123). (C) The normalized 2D histogram in (p,q)
space for all subjects. (D) Initial clusters with medians in (p,q) space. (E) Voronoi plot of final clusters (after 250 iterations of the k-means
algorithm). All clusters are colored using the D-SEG color mapping technique after 250 iterations (Fig. 2). Cluster numbers in (E) were assigned
based on median rank of p in each cluster. Specific segments are associated with increasing anisotropic diffusion (1 to 6), increasing isotropic
diffusion (1, 7, 9, 11, 13, 15, and 16), and increasing intermediate diffusivity (1, 8, 10, 12, and 14). Ellipses in (E) show the (p,q) range of
healthy tissue diffusivities (blue ¼ WM, yellow ¼ GM, green ¼ CSF).
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D-SEG Tumor Spectra
The volumetric proportion of each (p,q) segment to the VOI was
calculated for each case and averaged across tumor type
to generate D-SEG tumor spectra for low-grade glioma,
glioblastoma multiforme (GBM), cystic GBM, metastases, and
meningioma. Group spectra and classification were not per-
formed for the anaplastic astrocytoma case due to insufficient
group size (n¼ 1).
Table 1. Number and percent of voxels in each D-SEG segment at initialization and termination of the k-means algorithm
Segment Number Initial Conditions Algorithm Termination (250 iterations)
Number of
Constituent Voxels
Total Voxels, % Number of
Constituent Voxels
Total Voxels, % p (mm2 s21×1023) q (mm2 s21×1024)
1 4116043 4.66 9732194 11.01 1.22 1.85
2 5720616 6.47 9102275 10.30 1.30 2.86
3 6380942 7.22 6440093 7.29 1.32 3.85
4 5870246 6.64 4277553 4.84 1.34 5.00
5 5260481 5.95 9109123 10.31 1.36 6.59
6 5478436 6.20 7865938 8.90 1.45 9.41
7 5628352 6.37 7741129 8.76 1.45 1.19
8 5720574 6.47 2124115 2.40 1.57 2.11
9 8059367 9.12 7155477 8.10 1.94 1.40
10 6044389 6.84 4351102 4.92 2.03 3.14
11 4416182 5.00 3426063 3.88 2.54 1.73
12 3567915 4.04 1956397 2.21 2.79 4.68
13 4651951 5.27 5434604 6.15 3.26 2.05
14 4844407 5.48 4128078 4.67 3.85 7.73
15 5662375 6.41 3329037 3.77 4.20 3.03
16 6929118 7.84 2178216 2.47 5.48 4.96
Median coordinates in (p,q) space quantify diffusion characteristics for each segment.
Fig. 2. D-SEG color mapping technique. Ranked T2-weighted (red channel), p (green channel), and q (blue channel) maps are shown to the left of
D-SEG color maps for 2 axial slices of a healthy subject.
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Tumor Classification
The ability of D-SEG spectra to classify tumor type was tested
across all patients using SVMs.30 SVM predictions depend on
only a subset of the training data (ie, the support vectors).
The technique finds the hyperplane with the largest margin of
difference between classes.31 We used the Gaussian radial
basis function kernel (s¼ 1) to map feature vectors into a non-
linear feature space where an optimal hyperplane was con-
structed separating tumor classes. Tenfold cross-validation
was used to test classification accuracy and reproducibility. To
test the integrity of combining tumor DTI from 2 different scan-
ners, separate SVM classifications of D-SEG spectra acquired for
each acquisition protocol were performed (Table 2A and B).
Results
Between-Scanner Reproducibility
Mean and standard deviation for intraclass correlation coeffi-
cients for GM (0.915+0.097) and WM (0.890+0.110) in
healthy volunteers showed good interscanner reproducibility
of p and q diffusion metrics for healthy tissue.
D-SEG Algorithm
The D-SEG algorithm was computationally fast and reached
steady state by 50 iterations. Non-Gaussian characteristics
were apparent in p and q histograms (Fig. 1A and B) and in
the histogram of (p,q) space. The initial 16 segments assigned
to the (p,q) distribution and the final segmentation after 250
iterations are shown in Fig. 1D and E. Table 1 provides the initial
and final numbers of voxels in each segment and their median
(p,q) coordinates. The Voronoi plot (Fig. 1E) shows 3 radial lines
of segments through (p,q) space with unique diffusion charac-
teristics that include: tissue with mostly anisotropic diffusivity
(with q increasing from segment 1 to 6) but with lowest isotro-
pic diffusivity, isotropic diffusivity (with p increasing from seg-
ment 1 through 7, 9, 11, 13, 15, and 16), and intermediate
diffusivity (with p and q increasing from segment 1 through 8
and 12 to 14).
D-SEG Color Mapping
D-SEG color mapping is shown in Fig. 2 for a healthy subject. The
color mapping technique provides visually distinct colors based
on the diffusion and T2-weighted properties of the tissue in
each voxel. White matter regions with high anisotropic diffusion
are colored blue. Gray matter regions with low anisotropic and
isotropic diffusivities are yellow-brown with CSF colored pale
yellow.
D-SEG Spectra in Healthy Subjects
Gray matter, WM, and CSF voxels occupy different regions of
(p,q) space, as shown schematically by the ellipses in Fig. 1E,
and proportionately include different segment amounts result-
ing in characteristic D-SEG tissue spectra (Fig. 4A). Gray matter
predominantly includes segments 1, 2, 7, 8, and 9, representing
low isotropic and anisotropic diffusivities, whereas WM almost
exclusively includes segments 1 to 6, representing low isotropic
diffusion and increasing levels of anisotropic diffusion. CSF
spaces include high isotropic diffusion characteristics (seg-
ments 14, 15, and 16). Tissue partial volume effects will be pre-
sent in D-SEG segments because tissue class was not used to
define the segmentation.
Table 2. Cross-validated diagnostic results (n¼ 94), SVM analysis of D-SEG spectra
Tumor Type LGG GBM cGBM MET MEN Total Sens. Spec. Accu. 95% CI BER
A Confusion matrix—61 direction DTI
LGG 10 0 0 0 1 11 90.9 97.5 96.1 (86.5–99.5)
GBM 0 14 0 0 0 14 100 100
cGBM 0 0 6 0 0 6 100 100
MET 0 0 0 16 0 16 100 100
MEN 1 0 0 0 3 4 75 97.9
B Confusion matrix—12 direction DTI
LGG 7 0 0 0 1 8 87.5 100 93.0 (80.9–98.5)
GBM 0 17 0 0 0 17 100 96.2
cGBM 0 0 1 0 0 1 100 100
MET 0 1 0 9 0 10 90 97.2
MEN 0 0 0 1 6 7 85.7 97.2
C Confusion matrix—combined datasets
LGG 19 0 0 0 0 19 100.0 97.3 94.7 (88.0–98.3) 6.9
GBM 0 30 1 0 0 31 96.8 98.4
cGBM 0 1 6 0 0 7 85.7 98.9
MET 2 0 0 24 0 26 92.3 98.5
MEN 0 0 0 1 10 11 90.9 100.0
Abbreviations: cGBM, cystic GBM; LGG, low-grade glioma; MEN, meningioma; MET, metastasis. Sens., sensitivity (%); Spec., specificity (%); Accu.,
accuracy (%); BER, balanced error rate (%).
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Tumor Volume of Interest Delineation
Examples of the VOI extraction technique are shown in Fig. 3 for
low-grade glioma, glioblastoma, metastases, and meningio-
ma. Conventional fluid attenuated inversion recovery (row A)
and postcontrast T1-weighted images (row B) indicate the
tumor core, cystic, and edematous regions. D-SEG color maps
show the isotropic and anisotropic diffusion characteristics of
the tumor cases (row C) with the extracted VOIs (row D).
D-SEG color images show a visually apparent boundary be-
tween healthy and abnormal tissue (solid tumor, necrosis,
cyst, and edema) that relates to differences in diffusion charac-
teristics located in the regions identified as abnormal in the
conventional images. While lesion margins on conventional
MRI can be visually indistinct and rely on a subjective choice
of thresholding level, the colored segments obtained by
D-SEG provide a more objective boundary for semiautomatic
lesion delineation.
Tumor D-SEG Spectra
Figure 4B–F illustrates average D-SEG spectra obtained within the
VOIs for each tumor type. The low-grade glioma spectrum con-
sisted mostly of segments 9, 11, and 13, representing a lower an-
isotropic and higher isotropic diffusion relative to healthy WM.
High proportions of intermediate diffusivity segments 10 and
12 potentially represent partial volume effects between tumor
and WM tissue and were located at the tumor boundary. The
glioblastoma spectrum contained segments of low anisotropic
and isotropic diffusivity (segments 7 and 9, likely corresponding
to solid tumor) as well as segments with high isotropic and low
anisotropic diffusivity (segments 12 and 13, likely corresponding
to necrotic regions). High proportions of segments 8, 10, and 11
with greater isotropic diffusivities potentially represent edema re-
gions. Cystic glioblastoma spectra shared such diffusion charac-
teristics but with high proportions of segment 15 corresponding
to the cystic region. The D-SEG spectrum of metastases contains
Fig. 3. Individual patient images. From left to right: grade II glioma, glioblastoma with cystic component, cerebral metastasis, and meningioma
examples. (A) Fluid attenuated inversion recovery images, (B) T1-weighted postcontrast images, (C) D-SEG color maps, and (d) tumor volumes of
interest. All images are illustrated using the radiological convention.
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segments 1, 7, 8, and 9 (low isotropic and low anisotropic diffu-
sivity), corresponding to the solid tumor component. Segments
10 and 12 likely represent perilesional edema with isotropic diffu-
sivities greater than for glioblastoma. The D-SEG meningioma
spectrum is markedly different from the other tumor types,
with a large contribution from segments 1, 2, 3, and 4 (low iso-
tropic and increasing anisotropic diffusion), representing the solid
tumor component. In common with the metastases spectrum,
segments 10 and 12 represent the edema region.
Classification of Tumor Type
SVM analysis of the D-SEG spectra classified tumor type with
high overall accuracy (95% CI: 88.0%–98.3%) and low
balanced error rate of 6.9% after cross-validation (Table 2C).
Sensitivity and specificity of tumor classification was .90%
and 97%, respectively, for all tumor types except cystic glio-
blastoma. Separate SVM analysis of tumor spectra from the dif-
ferent DTI acquisitions reveals comparable accuracies (96.1%
CI: 86.5%–99.5% for 61-direction DTI vs 93.0% CI: 80.9%–
98.5% for 12-direction DTI; Table 2A and B).
Discussion
We present D-SEG, a fast segmentation and visualization tech-
nique that employs k-means clustering of (p,q) space to provide
tissue segments with different isotropic and anisotropic diffu-
sion properties. D-SEG maps were colored according to ranked
Fig. 4. D-SEG spectra. Average proportion of D-SEG segments within VOIs (standard error shown) for: (A) healthy tissue, (B) grade II glioma,
(C) glioblastoma, (D) glioblastoma with cystic component, (E) cerebral metastasis, and (F) meningioma.
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T2-weighted, p and q segment median values to provide a sim-
ple visualization of diffusion characteristics throughout the en-
tire brain that was then used to semiautomatically extract VOIs
of abnormal tissue. Distinct D-SEG tumor spectra representing
the proportion of diffusion segments within the VOI were com-
puted, and SVMs provided exceptionally high classification ac-
curacy among brain tumor types and grades.
Difficulties arise in multicenter studies incorporating MR dif-
fusion metrics due to variability in scanner magnetic field, gra-
dient strength, coil channels, and acquisition protocols.32
Despite the use of two 1.5T MR scanners with different maxi-
mum gradient strengths and acquisition protocols, the inter-
scanner reproducibility of p and q metrics was comparable to
previous studies.33,34 This led to consistent D-SEG spectral pat-
terns in healthy tissue and tumor VOIs for data acquired from 2
MR systems. A separate SVM subanalysis of tumor VOI D-SEG
spectra generated from the 2 different DTI acquisitions re-
vealed comparable diagnostic accuracies, confirming that the
datasets may be combined for the presented analysis.
The D-SEG technique separates (p,q) space into segments
with distinct isotropic and anisotropic diffusion properties.
Simultaneous application of D-SEG to all healthy and patient
data ensured that segments contained voxels with the same
diffusion properties in each individual. This allowed meaningful
between-subject comparison of D-SEG spectra. Nevertheless,
further work is required to evaluate stability of the final D-SEG
result due to perturbation of the initial algorithmic conditions
and for different numbers of tumor datasets. In this study, ini-
tial conditions were chosen that reflected the local density of
(p,q) space and consequently provided similar voxel numbers
per segment. Alternative segmentation techniques18 could be
applied, but an algorithmic investigation of optimality is beyond
the scope of this study. Interestingly (p,q) space is characterized
by a non-Gaussian distribution that does not contain explicit
data clusters. Nevertheless, D-SEG provides a discrete mapping
of this space dependent on local voxel density generating an in-
tuitive separation of isotropic and anisotropic diffusion.
D-SEG provides reproducible segmentation of GM, WM, and
CSF. Although D-SEG does not define exclusive segments for
each tissue type, it provides a spectrum of diffusion properties
supporting previous findings of similar isotropic diffusivity in GM
and WM, and heterogeneous anisotropic diffusion in WM.35
In this study, CSF spaces exhibited high magnitudes of isotropic
diffusion but also greater anisotropic diffusion than did GM. This
effect was caused by the use of q to quantify anisotropic diffu-
sion, which, unlike FA, is not scaled by the overall magnitude of
diffusion within a voxel.17
We prospectively recruited 94 patients with histopathologi-
cally confirmed lesions occupying intracranial space over an
18-month period representing a cross section of brain tumors
encountered in our neurosurgical practice. D-SEG analysis of
these data show that combined tumor and edema VOIs deter-
mined by D-SEG correspond visually with the extent of tumor on
standard MRI; however, their complex margins are indistinct on
conventional MRI or within p and q maps. A range of region
drawing techniques have been used to determine diffusion char-
acteristics of tumors, such as from manually drawn lesion
edges36 or from within ROIs placed in specified brain regions.37
These techniques are time-consuming and user dependent and
are subjective interpretations of the tumor boundary.38 In
contrast, D-SEG generates tissue type boundaries based on an
objective clustering of the isotropic and anisotropic diffusivities
in (p,q) space. Such segmentation may reflect underlying differ-
ences in tissue microstructure and potentially relevant patholog-
ical boundaries. However, partial volume effects may result in
D-SEG boundaries that do not accurately represent the precise
difference between pathological and healthy tissue, and further
work is required to determine the histological ground truth of
D-SEG boundaries.
Brain tumors are characterized by their heterogeneity in
size, location, and extent of perilesional edema.39 Limitations
of previous brain tumor diffusion studies are twofold: (i) place-
ment of ROIs significantly smaller than the lesion potentially
excludes relevant diffusion information; (ii) computation of
average information over whole-lesion ROIs obscures hetero-
geneous diffusion characteristics within the tumor. Spectral
comparison using D-SEG overcomes these limitations by pro-
viding a pattern of diffusivity across the entire region of abnor-
mal tissue.
D-SEG spectra differ among tumor types in both their con-
stituent segment numbers and their proportional contribution
to the VOI. Spectra are consistent within the tumor type, con-
firmed by small standard errors for segments despite variability
in size, location, natural history, and, in the case of metastases,
cellular origin of each lesion. Possible reasons for differences in
diffusion characteristics between tumor types include presence
of necrotic or cystic regions or volumetric proportion of tumor
and edema, solid tumor microstructure, and pathophysiology
of perilesional edema.
Malignant tumors are characterized by rapid growth and
neovascularity. When tumor rate of growth exceeds its blood
supply, cell death and regional necrosis result.40 The loss of cel-
lular structure and boundaries to diffusion results in higher iso-
tropic diffusion41 and is observed in glioblastoma D-SEG
spectra. Tumor cysts may result from necrotic degeneration,
central hemorrhage, liquefaction, entrapment of CSF, and plas-
ma fluid leaking from a disrupted blood–brain barrier.42 Cysts
have high isotropic diffusivity in the D-SEG spectra, reflecting
the fluid nature of these regions. Glioblastoma cysts exhibit
lower isotropic diffusivity than normal CSF spaces, potentially
reflecting their proteinaceous constituents.
The solid component of tumors consists of disorganized
pleomorphic, hypercellular cells with hyperchromatic nuclei,
lacking the organized structure of nascent neural tissue.43 In
common with previous studies, D-SEG spectra indicate that iso-
tropic diffusion within the solid tumor contributes to differenti-
ating among tumor types.41,44,45 In particular, differences in
cell density of the solid tumor may be responsible for observed
spectral differences in the proportion of isotropic and anisotrop-
ic segments among tumor types. Our results confirm that iso-
tropic diffusion is smaller in glioblastoma than in low-grade
glioma, agreeing with previous studies,37,46,47 and contrasts
the high cellularity of glioblastoma with cellularity that is only
moderately increased compared with normal brain in low-
grade glioma. D-SEG spectra confirm a lower isotropic diffusion
within the solid component of metastases than glioblastoma,
agreeing with previous studies.7,36 This contrasts the densely
packed and restricted diffusion within secondary tumors with
the irregular cellular arrangement of microscopic necrosis in
glioblastoma. Meningioma D-SEG spectra are markedly
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different from the other tumor types. The solid tumor compo-
nent has the lowest isotropic diffusion and an anisotropic diffu-
sion component that likely reflects interdigitating cellular
processes, tight intercellular junctions, and formation of fascic-
ular and lobular tissue in association with whorls and psam-
moma bodies.
D-SEG spectra differ in segments containing perilesional
edema. Tumors with vasogenic edema, such as metastases
and meningioma, comprise a greater proportion of segments
with higher isotropic diffusion than infiltrative cellular edema
in glioblastoma. These findings agree with previous studies
and reflect the differences in pathophysiology of the
edema.36,46
Due to the ability of D-SEG to capture differences among tu-
mors, it provides exceptional accuracy in tackling clinically rel-
evant diagnostic scenarios, including differentiating glioma
grade and discriminating between isolated metastases and
glioblastoma. Although D-SEG accurately distinguishes metas-
tases and meningioma, this has limited clinical use except for
differentiating durally based metastatic deposits from benign
meningioma.
D-SEG delineated a clear boundary between tumor and
normal-appearing brain tissue for all except a small number
of meningioma cases. In these cases the meningioma dis-
played anisotropic diffusion properties similar to healthy WM.
Here it was necessary to manually draw lesion boundaries for
the VOI guided by conventional postcontrast T1-weighted im-
ages. A further limitation is that diffusion properties identified
by D-SEG are not exclusively representative of healthy or path-
ological tissue types due to tissue partial volume effects, ef-
fects of noise, and certain tumor tissue types sharing similar
diffusivities to healthy brain tissue. The use of D-SEG spectra
overcomes these problems by providing proportions of seg-
ments within VOIs. The 94 brain tumor cases acquired in this
study represent the largest reported cohort of tumor DTI
data. Further evaluation of the role of D-SEG in diagnosis re-
quires comparing the accuracy of this method with the accura-
cy of reporting of conventional imaging, as well as testing with
other tumor types and grades and a range of different metas-
tases, as the site of primary disease and thus cell lineage may
influence microstructure and thus tumor p-q diffusion
characteristics.
Conclusion
Advances in imaging of newly identified lesions occupying in-
tracranial space have not eliminated the requirement for histo-
pathological “tissue” diagnosis in the majority of cases. With an
increasing elderly population, improved survival in systemic
malignancy, and increased detection of lesions (potentially in-
cidentally) at an early stage, there exists a need for accurate
and reproducible noninvasive diagnostic tools. In this study,
we present a technique capable of classifying brain tumors
using biomarkers obtained from DTI with an accuracy of
94.7%. The potential roles for D-SEG include: (i) delineation of
lesion margins for optimal surgical resection or radiotherapy
treatment, (ii) serial volumetric analysis to monitor changes
in low-grade glioma over time or evaluate response to onco-
therapy, and (iii) regional assessment of biomarkers for diagno-
sis or surveillance. Further studies are required to replicate
these results and determine the additional utility of D-SEG in
these and other clinical scenarios.
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